APP and Alzheimer disease: The APPswe/PS1dE9 (APP/PS1) transgenic mouse model develops spatial memory impairment, increased Aβ deposition in the brain [30], synaptic loss, and mitochondrial dysfunction similar to those features observed in AD [31, 32].